Get the Stockscreener App
0.071
11.25%
-0.009
After Hours:
.07
-0.0010
-1.41%
Hepion Pharmaceuticals Inc stock is traded at $0.071, with a volume of 1,369.
It is down -11.25% in the last 24 hours and down -2.14% over the past month.
See More
Previous Close:
$0.08
Open:
$0.08
24h Volume:
1,369
Relative Volume:
0.04
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
$-13.56M
P/E Ratio:
-0.00628
EPS:
-11.31
Net Cash Flow:
$-6.30M
1W Performance:
-11.25%
1M Performance:
-2.14%
6M Performance:
-19.32%
1Y Performance:
-99.85%
1-Day Range:
$0.071
$0.08
1-Week Range:
$0.071
$0.08
52-Week Range:
$0.046
$0.10
Hepion Pharmaceuticals Inc Stock (HEPA) Company Profile
Name
Hepion Pharmaceuticals Inc
Sector
Industry
Phone
-
Address
-
Compare HEPA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HEPA
Hepion Pharmaceuticals Inc
|
0.071 | 0 | 0 | -13.56M | -6.30M | -11.31 |
|
VRTX
Vertex Pharmaceuticals Inc
|
447.38 | 114.05B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
748.71 | 78.80B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
396.04 | 51.80B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
847.05 | 53.08B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
166.55 | 42.33B | 447.02M | -1.18B | -906.14M | -6.1812 |
Hepion Pharmaceuticals Inc Stock (HEPA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-20-20 | Resumed | ROTH Capital | Buy |
Hepion Pharmaceuticals Inc Stock (HEPA) Latest News
Why Hepion Pharmaceuticals Inc. stock could rally in 2025Trade Exit Report & Fast Gain Swing Trade Alerts - Улправда
Can Hepion Pharmaceuticals Inc. (336) stock sustain breakout momentumDividend Hike & Community Supported Trade Ideas - Улправда
Growth Report: How Hepion Pharmaceuticals Inc. stock trades during market volatilityGap Up & Risk Controlled Daily Trade Plans - Улправда
Why Hepion Pharmaceuticals Inc. stock is considered a top pickRisk Management & Reliable Breakout Forecasts - Улправда
Will Hepion Pharmaceuticals Inc. (336) stock outperform foreign stocksQuarterly Profit Report & Real-Time Volume Analysis - Newser
Why Hepion Pharmaceuticals Inc. (336) stock benefits from AI revolutionJuly 2025 Price Swings & Free Weekly Chart Analysis and Trade Guides - Newser
How Hepion Pharmaceuticals Inc. (336) stock reacts to Fed tighteningWeekly Trade Review & Entry Point Confirmation Signals - Newser
Is Hepion Pharmaceuticals Inc. (336) stock undervalued historicallyVolume Spike & Reliable Price Action Trade Plans - Newser
How Hepion Pharmaceuticals Inc. (336) stock behaves under inflation pressureMarket Risk Analysis & Weekly High Potential Stock Alerts - Newser
What dividend safety score for Hepion Pharmaceuticals Inc. stockWeekly Investment Recap & Weekly Breakout Stock Alerts - Newser
Is Hepion Pharmaceuticals Inc. (336) stock a good hedge against inflationTrade Analysis Summary & Safe Entry Trade Reports - newser.com
Is Hepion Pharmaceuticals Inc. stock attractive after correctionJuly 2025 Patterns & Free Fast Entry Momentum Trade Alerts - newser.com
Can Hepion Pharmaceuticals Inc. stock sustain revenue growth2025 Institutional Moves & Fast Momentum Stock Entry Tips - newser.com
Will Hepion Pharmaceuticals Inc. (336) stock benefit from infrastructure bill2025 EndofYear Setup & Precise Swing Trade Alerts - newser.com
Is Hepion Pharmaceuticals Inc. (336) stock resilient in recession scenariosEarnings Beat & Accurate Entry and Exit Point Alerts - newser.com
Does Hepion Pharmaceuticals Inc. show high probability of reboundEarnings Overview Summary & Smart Money Movement Alerts - newser.com
Trend analysis for Hepion Pharmaceuticals Inc. this weekWeekly Stock Report & AI Forecasted Entry/Exit Points - newser.com
How Hepion Pharmaceuticals Inc. (336) stock valuation compares with sectorTrade Volume Report & Low Risk Growth Stock Ideas - newser.com
Candlestick signals on Hepion Pharmaceuticals Inc. stock todayPortfolio Gains Report & Technical Confirmation Trade Alerts - newser.com
Hepion Pharmaceuticals Inc Stock (HEPA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.31%
0.33%
Cap:
|
Volume (24h):